Skip to content
Open access

Early Low-Density Lipoprotein Cholesterol Target Attainment Is Associated With Fewer Recurrent Cardiovascular Events After Acute Myocardial Infarction: A Real-World Cohort Study.

Sep 2026 · American Journal of Cardiology · Vol 278, pp. 70-74 · 0 citations · 18 references
Medicine

TL;DR

Achievement of LDL-C <55 mg/dL within 6 months after AMI is independently associated with a meaningful reduction in recurrent ASCVD events in real-world practice, and the temporal mismatch between early post-discharge risk and delayed lipid assessment underscores the need for proactive, multidisciplinary care models to close this implementation gap.

Abstract

Survivors of acute myocardial infarction (AMI) face high risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events within the first year after discharge, yet real-world achievement of guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets <55 mg/dL remains limited. We conducted a retrospective cohort study of 12,815 adults hospitalized with type 1 AMI between January 1, 2015, and December 31, 2024, within the Rush University Health System in Chicago, Illinois, to evaluate the association between LDL-C <55 mg/dL attainment at approximately 6 months post-discharge and recurrent ASCVD events within 12 months. The primary outcome was a composite of non-fatal MI, unstable angina hospitalization, ischemic stroke, or unplanned coronary revascularization. Among 12,810 patients with available follow-up LDL-C data, 999 (7.8%) achieved the <55 mg/dL target. A total of 4,692 patients (36.6%) experienced a recurrent composite event within 12 months, and all-cause mortality at 12 months was 11.8%. The elevated event rate is attributable to the inclusive composite definition and to administrative coding practices in which hospital readmissions are frequently assigned AMI ICD-10 codes in patients with recent MI history, rather than reflecting true adjudicated MI recurrence. In unadjusted analyses, LDL-C goal attainment was paradoxically associated with higher odds of recurrent events (odds ratio [OR] 1.81; 95% confidence interval [CI] 1.59-2.06; p <0.001), consistent with confounding by indication: patients receiving the most intensive lipid-lowering therapy had the highest underlying cardiovascular risk. After multivariable adjustment for age, comorbidities, statin use, and admitting hospital, LDL-C <55 mg/dL attainment was associated with lower odds of recurrent events (adjusted OR 0.84; 95% CI 0.75-0.97; p = 0.007). LDL-C goal attainment was not significantly associated with all-cause mortality at 12 months (adjusted OR 0.91; 95% CI 0.73-1.14; p = 0.41), consistent with published literature requiring longer follow-up to demonstrate a mortality signal. These findings highlight persistent underattainment of guideline-recommended lipid targets and underscore substantial clinical inertia in post-AMI lipid management, with first LDL-C reassessment occurring at a mean of 85 days post-discharge while recurrent events occurred a mean of 49 days after admission. In conclusion, achievement of LDL-C <55 mg/dL within 6 months after AMI is independently associated with a meaningful reduction in recurrent ASCVD events in real-world practice, and the temporal mismatch between early post-discharge risk and delayed lipid assessment underscores the need for proactive, multidisciplinary care models to close this implementation gap.

Read PDF

Similar papers

Open access Oct 2026

Prognostic Value of the Non-HDL-C/HDL-C Ratio for Predicting One-Year Major Adverse Cardiac and Cerebrovascular Events in Young Patients with Myocardial Infarction.

OBJECTIVE Young patients with myocardial infarction (MI) remain at risk for recurrent cardiovascular events despite favorable short-term outcomes. The prognostic significance of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio in this population remains insuff...

M. Keten, Kadir Bıyıklı · 0 citations
Open access Oct 2026

Estimated small dense low-density lipoprotein cholesterol and incident myocardial infarction in patients undergoing dialysis: a nationwide cohort study

Abstract Background Small dense low-density lipoprotein cholesterol (sdLDL-C) is an atherogenic LDL subfraction that may reflect lipid-related coronary risk beyond conventional cholesterol levels. Estimated sdLDL-C (E-sdLDL-C) is calculated from a standard lipid panel, but its prognostic relevance for myocardial infarc...

B. Kim, Hyun-Jin Kim, Jiyeong Kim et al. · 0 citations
Open access Oct 2026

The independent association of mortality with LDL-C management, and number and types of atherosclerotic cardiovascular disease events: a large nationwide real-world cohort study

In a large nationwide cohort, recurrent ASCVD events and multi-bed disease were associated with markedly higher mortality compared to patients experiencing single ASCVD events, highlighting the need for earlier, more intensive, and sustained prevention- particularly aggressive LDL-C lowering and comprehensive risk fact...

M. H. Moshe Hoshen, V. B. Vishal Bali, S. Moser et al. · 0 citations
Open access Oct 2026

LDL-c levels and clinical outcomes in acute myocardial infarction patients with prior ischemic stroke

The optimal low-density lipoprotein cholesterol (LDL-c) target after acute myocardial infarction (AMI) in patients with prior ischemic stroke remains uncertain, particularly regarding the trade-off between ischemic protection and bleeding risk. We evaluated the association between LDL-c levels achieved at three m...

Y.-K. Zhang, R. Guo, Z. Xue et al. · 0 citations
Open access Sep 2026

Prognostic value of combined LDL-C and remnant cholesterol stratification for 24-month major adverse cardiovascular events after primary PCI in patients with STEMI

Elevated RC, rather than isolated high LDL-C, is associated with adverse outcomes, which may help identify patients with residual lipid-related risk, which may help identify patients with residual lipid-related risk in STEMI patients after primary PCI.

Qian-Ying Xie, Chao-Yi Wang, Wen-Jing Zhao et al. · 0 citations
Open access Oct 2026

Clinical impact of more than 50% reduction in low-density lipoprotein cholesterol at 6 weeks after percutaneous coronary intervention for acute coronary syndrome

Early intensive lipid-lowering therapy is recommended after acute coronary syndrome (ACS), and current guidelines recommend assessing attainment of lipid-lowering targets within 4–6 weeks; however, the prognostic significance of achieving a more than 50% reduction in low-density lipoprotein cholesterol (LDL-C) sh...

K. Murai, K. Mitsui, T. Iwai et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.